Antiresorptive Drug Continuation Compared With Drug Holiday in Cancer Patients Needing Tooth Extraction

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

August 1, 2019

Study Completion Date

August 19, 2020

Conditions
Osteonecrosis Due to Drugs, Jaw
Interventions
OTHER

Continuation of antiresorptives in relation to tooth extraction (surgical tooth removal)

"We want to investigate the importance of an antiresorptive drug holiday (bisphosphonate, denosumab) in relation to tooth extraction. The experimental intervention in this trial is drug continuation starting before tooth extraction with primary closure.~We simply ask the participating cancer patients to continue their high dose antiresorptive treatment for 4 months (intervention-period: 1 month pre-operative, 3 months post-operative) instead of taking a drug holiday."

Trial Locations (2)

2100

Copenhagen University Hospital, Copenhagen

2200

University of Copenhagen, Department of Odontology, Copenhagen

All Listed Sponsors
collaborator

Department of Oral and Maxillofacial Surgery, Copenhagen University Hospital

UNKNOWN

lead

University of Copenhagen

OTHER

NCT04540601 - Antiresorptive Drug Continuation Compared With Drug Holiday in Cancer Patients Needing Tooth Extraction | Biotech Hunter | Biotech Hunter